Intech Investment Management LLC Neurocrine Biosciences Inc Transaction History

Intech Investment Management LLC

$10 Billion
Q4 2024

A detailed history of Intech Investment Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 118,414 shares of NBIX stock, worth $13.1 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

118,414

Previous 102,595 15.42%

Holding current value

$13.1 Million

Previous $11.8 Million 36.85%

% of portfolio

0.16%

Previous 0.14%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$111.62 - $139.44 $1.77 Million - $2.21 Million	15,819 Added 15.42%	118,414 $16.2 Million
Q3 2024 Nov 08, 2024	BUY	$114.58 - $153.15 $3.88 Million - $5.19 Million	33,897 Added 49.34%	102,595 $11.8 Million
Q2 2024 Aug 12, 2024	BUY	$130.86 - $143.19 $5.82 Million - $6.37 Million	44,512 Added 184.04%	68,698 $9.46 Million
Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $1.55 Million - $1.71 Million	11,921 Added 97.2%	24,186 $3.34 Million
Q4 2023 Oct 18, 2024	SELL	$106.07 - $132.76 $565,140 - $707,345	-5,328 Reduced 30.28%	12,265 $1.62 Million
Q4 2023 Feb 09, 2024	SELL	$106.07 - $132.76 $565,140 - $707,345	-5,328 Reduced 30.28%	12,265 $1.62 Million
Q3 2023 Oct 18, 2024	SELL	$94.02 - $117.1 $290,333 - $361,604	-3,088 Reduced 14.93%	17,593 $1.98 Million
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $402,593 - $501,422	-4,282 Reduced 19.57%	17,593 $1.98 Million
Q2 2023 Oct 18, 2024	BUY	$89.53 - $104.87 $1.47 Million - $1.72 Million	16,398 Added 382.86%	20,681 $1.95 Million
Q2 2023 Aug 09, 2023	BUY	$89.53 - $104.87 $1.47 Million - $1.72 Million	16,398 Added 299.4%	21,875 $2.06 Million
Q1 2023 Oct 18, 2024	SELL	$94.11 - $123.02 $6.06 Million - $7.92 Million	-64,415 Reduced 93.77%	4,283 $433,000
Q1 2023 May 10, 2023	SELL	$94.11 - $123.02 $28,515 - $37,275	-303 Reduced 5.24%	5,477 $554,000
Q4 2022 Oct 18, 2024	BUY	$106.72 - $127.06 $32,336 - $38,499	303 Added 7.07%	4,586 $547,000
Q4 2022 Feb 09, 2023	BUY	$106.72 - $127.06 $159,759 - $190,208	1,497 Added 34.95%	5,780 $690,000
Q3 2022 Oct 18, 2024	SELL	$92.03 - $107.81 $5.93 Million - $6.94 Million	-64,415 Reduced 93.77%	4,283 $454,000
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $28,253 - $33,097	307 Added 7.72%	4,283 $455,000
Q2 2022 Aug 10, 2022	BUY	$75.79 - $100.07 $301,341 - $397,878	3,976 New	3,976 $388,000

Others Institutions Holding NBIX

# of Institutions

656

Shares Held

95.2M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.6B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Account

Intech Investment Management LLC Neurocrine Biosciences Inc Transaction History